Lawyers and Settlements
Advertisement
Home Page >> Taxotere Permanent Hair Loss Lawsuits >> Articles

Taxotere Hair Loss Articles

Permanent Taxotere Hair Loss for Cancer Patients a Particularly Cruel Fate

Permanent Taxotere Hair Loss for Cancer Patients a Particularly Cruel Fate June 19, 2017. By Gordon Gibb.
New Orleans, LA: Understanding the choice that some women make in their selection of Taxotere for treatment of breast cancer, means understanding the busy lives and compelling responsibilities that modern women maintain. It is also easy to understand why plaintiffs embroiled in Taxotere hair loss lawsuits, may have been misled over the potential for permanent Taxotere alopecia.
Read [ Permanent Taxotere Hair Loss for Cancer Patients a Particularly Cruel Fate ]

Number of Taxotere Multidistrict Litigation Cases Surpass 1,100

Number of Taxotere Multidistrict Litigation Cases Surpass 1,100 June 3, 2017. By Deb Hipp.
New Orleans, LA: A Louisiana multidistrict litigation (MDL) that began in 2016 with less than three dozen transferred Taxotere lawsuits has now swelled to more than a thousand pending cases.
Read [ Number of Taxotere Multidistrict Litigation Cases Surpass 1,100 ]

Generic Docetaxel Inclusion in Taxotere MDL Significant Departure

Generic Docetaxel Inclusion in Taxotere MDL Significant Departure May 24, 2017. By Brenda Craig.
Philadelphia, PA Eight Manufacturers of a generic form of Taxotere known as Docetaxel are also being included in the ongoing MDL in U.S. District Court, Eastern District of Louisiana (New Orleans). As a result, more women will likely join the approximately 1,000 women already involved in the litigation.
Read [ Generic Docetaxel Inclusion in Taxotere MDL Significant Departure ]

Taxotere Hair Loss Patients Speak Out Over the Fallout

Taxotere Hair Loss Patients Speak Out Over the Fallout May 15, 2017. By Gordon Gibb.
Washington, DC: A recent filing by Taxotere manufacturer Sanofi Aventis with the US Securities and Exchange Commission (SEC) revealed the current state of Taxotere hair loss lawsuits as of the end of the pharmaceutical’s fiscal year ending December 31, 2016.
Read [ Taxotere Hair Loss Patients Speak Out Over the Fallout ]

Pharmaceuticals Fast-Tracked to Market through Little-Known FDA Protocol

Pharmaceuticals Fast-Tracked to Market through Little-Known FDA Protocol April 20, 2017. By Gordon Gibb.
New Orleans, LA: An interesting sidebar to Taxotere hair loss litigation has opened up through a peek into docetaxel hair loss multidistrict litigation, and an accompanying analysis of the various approval protocols employed to bring both branded and generic docetaxel (Taxotere) to the market.
Read [ Pharmaceuticals Fast-Tracked to Market through Little-Known FDA Protocol ]

Science Day Scheduled For Taxotere Multidistrict Litigation

Science Day Scheduled For Taxotere Multidistrict Litigation April 7, 2017. By Deb Hipp.
New Orleans, LA A multidistrict litigation of hundreds of Taxotere lawsuits alleging that the chemotherapy drug Taxotere causes permanent hair loss continues to move forward in federal court with a "Science Day" scheduled in May.
Read [ Science Day Scheduled For Taxotere Multidistrict Litigation ]

California Women Suffers Permanent Hair Loss after Taxotere Chemo – Suit Claims

California Women Suffers Permanent Hair Loss after Taxotere Chemo – Suit Claims March 29, 2017. By Brenda Craig.
San Francisco, CA In 2010, Ami Dodson was diagnosed with stage two breast cancer and underwent a partial mastectomy to remove the cancer. Her oncologists suggested they follow up with chemotherapy treatments using a drug known as Taxotere. Her prognosis was excellent and there was every expectation she would live a normal life.
Read [ California Women Suffers Permanent Hair Loss after Taxotere Chemo – Suit Claims ]

Potential for Permanent Taxotere Hair Loss Not Widely Promoted

Potential for Permanent Taxotere Hair Loss Not Widely Promoted March 4, 2017. By Gordon Gibb.
New Orleans, LA: As important as it is to be aware of any, and all side effects associated with a drug such as Taxotere, patients in need of the chemotherapy drug are already coming from a position of significant physical and emotional challenge: the fallout from a cancer diagnosis. And while most cancer patients are aware that hair loss is a common byproduct of chemotherapy and cancer treatments, many would not be cognizant about the potential for Taxotere hair loss to be permanent.
Read [ Potential for Permanent Taxotere Hair Loss Not Widely Promoted ]

Number of Taxotere MDL Lawsuits Surpasses 700 Cases

Number of Taxotere MDL Lawsuits Surpasses 700 Cases February 27, 2017. By Deb Hipp.
New Orleans, LA: In a joint report filed in federal court in January, attorneys representing plaintiffs and defendant Sanofi S.A. in multidistrict litigation of Taxotere lawsuits reported a spike in the number of lawsuits alleging that the chemotherapy drug Taxotere causes permanent hair loss, a condition known as alopecia.
Read [ Number of Taxotere MDL Lawsuits Surpasses 700 Cases ]

Taxotere Hair Loss Lawsuits Moving Forward in MDL

Taxotere Hair Loss Lawsuits Moving Forward in MDL February 15, 2017. By Gordon Gibb.
New Orleans, LA: The 800 lawsuits currently enshrouded in Taxotere hair loss multidistrict litigation are moving forward by way of updated orders and directives issued February 1 by the US District Court for the Eastern District of Louisiana. Plaintiffs assert that Taxotere, a chemotherapy drug, triggered Taxotere alopecia (hair loss) that has been characterized as permanent.
Read [ Taxotere Hair Loss Lawsuits Moving Forward in MDL ]

Request Taxotere Hair Loss Legal Help

First name:

Last name:

Email address:

Phone number(s):

Zip/Postal Code:

Defendant:
Describe your complaint:

By submitting this form I agree to the Terms of Service.
There is no cost to submit this form.
I would like to be interviewed by a journalist.
Receive our weekly newsletter with the latest lawsuit news and legal information.

Check Claim Status Advertise with us Legal Funding


Legal Services:

Advertisement
 
FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map | View Mobile Website

American Bar Association - Proud Member   Better Business Bureau   CAALA   Best of the Web Approved   Public Justice


This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2017 Online Legal Media. All rights reserved.


Visit other Online Legal Media Websites:

BigClassAction.comCALaborLawNews.com
OnlineLegalMarketing.comHealthEffectsOfAsbestos.com